Companies Related to "Biosciences" [Most Relevant Company Matches] RSS

11:13 EDT 16th July 2019 | BioPortfolio

Here are the most relevant search results for "Biosciences" found in our extensive corporate database of over 50,000 company records.

Showing "Biosciences" Companies 1–25 of 399

Tuesday 9th July 2019

Annexon Biosciences

Annexon’s pipeline of novel therapies includes two clinical-stage product candidates, ANX005, a monoclonal antibody, and ANX007, a fragmented monoclonal antibody, as well as other compounds in preclinical development. ANX005 is currently in a Phase 1/2 study in patients with Guillain-Barre Syndrome (GBS). Annexon also plans to evaluate ANX005 in complement-mediated neurodegenerative disorder...

Thursday 20th June 2019

Tangen Biosciences, Inc.

Tuesday 18th June 2019

Element Biosciences, Inc.

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. The Company's technology will broaden the end user experience through improved data quality and simplified workflows to benefit discoveries and diagnosis in healthcare. For more information, visit ...

Wednesday 12th June 2019

Senti Biosciences

Senti Biosciences is a next-generation therapeutics company that is developing gene circuits and programming cells for tremendous therapeutic value. Our mission is to outsmart complex diseases with more intelligent medicines that will transform people’s lives. By programming cells to respond, adapt and make decisions, we are creating smarter therapies...

Wednesday 5th June 2019

System Biosciences

System Biosciences (SBI) focuses on developing unique, innovative technologies that provide researchers with the tools to investigate and understand genomic and proteomic function. Our mission is to provide tools for the genome-wide analysis of the mechanisms that regulate cellular processes and biological responses. One example is our effector expression library technology.Headquartered in Moun...

Monday 22nd April 2019

Paragon Biosciences, LLC

Paragon is a life science innovator that invests in, builds, and advises bioscience companies. Our mission is to serve patients living with severe medical conditions which do not yet have adequate treatments. Paragon’s portfolio of independently-run bioscience companies focus on: biopharmaceuticals, AI-enabled life science products, and advanced treat...

Tuesday 16th April 2019

ACEA Biosciences, a part of Agilent Technologies

ACEA Biosciences, a part of Agilent Technologies, is a pioneer in the development and commercialization of high-performance cell analysis platforms for life science research. ACEA’s xCELLigence® Real-Time Cell Analysis instruments and NovoCyte® Quanteon flow cytometers are used in pre-clinical drug discovery and development, toxicology, safety p...

Wednesday 10th April 2019

OZ Biosciences

OZ Biosciences is a product development company that creates, develops and commercializes delivery systems of bioactive materials. These laboratory reagents, intended for the worldwide scientific community, allow researchers to study more effectively the functions of genes, proteins or other molecules delivered.Our vocation is to design innovative, efficient and adapted tools specialized in the tr...

Tuesday 9th April 2019

xCella Biosciences

xCella is an antibody engineering and drug discovery company based on intellectual property originally developed at Stanford University in the Stanford Photonics Research Center and the laboratory of Dr. Jennifer Cochran in the Stanford Department of Bioengineering. The xPlorationTM platform enables high throughput screening of millions of B cells based on...

Tuesday 2nd April 2019

Reveal Biosciences, Inc.

Reveal Biosciences is focused on improving global healthcare by creating a new generation of objective, data-powered pathology to characterize and detect disease. With extensive scientific and computational expertise, the company is uniquely positioned to lead the digital pathology revolution. Our proprietary deep-learning platform, ImageDx™, delivers...

Friday 22nd March 2019

Akoya Biosciences, Inc.

Akoya Biosciences is committed to developing powerful imaging tools to enable scientists and clinical researchers gain a better understanding of complex diseases such as cancer. The company offers the most comprehensive end-to-end solution for high-parameter tissue analysis from discovery through clinical and translational research, enabling more precise t...

Thursday 21st March 2019

Imago BioSciences, Inc.

Imago BioSciences is a clinical-stage, venture-backed pharmaceutical company focused on improving the management of proliferative diseases of the bone marrow and modulation of the immune system. The company is currently focused on neoplastic diseases of the bone marrow including acute myeloid leukemia, myelodysplastic syndrome, polycythemia vera, myelofibr...

Sherlock Biosciences

Sherlock Biosciences is dedicated to making molecular diagnostics better, faster and more affordable through Engineering Biology platforms. The company is developing applications of SHERLOCK™, a CRISPR-based method to detect and quantify specific genetic sequences, and INSPECTRTM, a Synthetic Biology-based molecular diagnostics platform that is instru...

Wednesday 20th March 2019

Eos Biosciences, Inc.

Eos Biosciences, Inc. is a bio-targeted nanomedicines company based in Los Angeles, California with world-wide, exclusive rights to a novel and innovative drug-targeting and delivery platform technology developed at Cedars-Sinai Medical Center in Los Angeles. The technology facilitates the effective delivery of approved and novel therapeutics to disease ...

Dyve Biosciences

Dyve Biosciences is rapidly developing a strong pipeline across a broad range of therapeutic areas based around its proprietary Dyve skin penetration technology. The innovative approach enables therapy to be transported fast and deep through the skin, allowing rapid penetration into targeted tissue. This unique approach offers the promise of delivering the...

Tuesday 26th February 2019

Emtora Biosciences

Researchers at UT Health San Antonio discovered that an improved, targeted formulation of the well-known drug rapamycin extended life span and health span in rodents by mitigating the effects of age-related diseases. Emtora, as the exclusive licensee of this technology, is strategically developing and commercializing its drug compound, eRapa, for indicatio...

Wednesday 20th February 2019

Codiak BioSciences, Inc.

Codiak BioSciences is harnessing exosomes—natural intercellular messengers—to pioneer a new class of biologic medicines, exosome therapeutics. We have developed the engEx Platform, our proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Us...

Monday 4th February 2019

NanoView Biosciences, Inc.

NanoView Biosciences, a Boston-based, privately-held company, is focused on enabling life science researchers to better understand the biological role of exosomes and their potential use as biomarkers for improving the diagnosis, prognosis, treatment, and monitoring of disease. The company’s proprietary product, the ExoView™ system, was designed to ...

Monday 7th January 2019

Paragon Biosciences

For severe and complex diseases, Paragon Biosciences identifies unmet patient needs, invests in novel therapies to treat those medical conditions, launches biopharmaceutical companies to further develop those therapies, and supports these new portfolio companies with early-incubation services. After which, the portfolio companies operate independently as t...

Thursday 3rd January 2019

iota Biosciences

Wednesday 12th December 2018

InterVenn BioSciences

InterVenn BioSciences aims to find solutions for the most challenging health problems. InterVenn’s approach combines the analysis of glycoproteomics using mass spectrometry with data science and artificial intelligence to quickly identify potentially actionable and clinically relevant information for conditions including cancers, autoimmunity, fibrosi...

Thursday 6th December 2018

Brii Biosciences

Brii Biosciences (Brii Bio) is a company committed to serving patients’ needs and improving public health in China. Founded in early 2018 with operations in the People’s Republic of China and the United States, the company focuses on accelerating innovation and optimizing access to the latest medicines for Chinese patients. Brii Bio helps global partner...

Wednesday 21st November 2018


EVIO Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The Company's EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation's cannabis supply. The Company's EVIO Biosciences Division is dedicated to the scientific, medica...

Thursday 1st November 2018

Ark Biosciences

Ark Biosciences is a privately held, clinical-stage global biotechnology company with its corporate office located in ZhangJiang Hi-Tech Park in Shanghai, its R&D Center in Suzhou Biobay, China, and offices in the United States, Australia, and Switzerland. Ark Biosciences has its own active R&D programs and programs in collaboration with external partners....

Wednesday 31st October 2018

Akoya Biosciences

To register for the event, visit us at:

More From BioPortfolio on "Biosciences"

Quick Search


Corporate Database Quicklinks